Skip to Main Content
Keywords: I10
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal of Economic Studies (2025) 52 (9): 174–192.
Published: 13 August 2025
... Efficacy Lung diseases Biosimilar drugs Systematic literature review A10 H41 I10 Cost-effectiveness analysis (CEA) is an intricate and systematic approach that facilitates the assessment and scrutiny of both the financial implications and health outcomes associated with various medical...
Includes: Supplementary data
Journal Articles
Journal Articles
Journal of Economic Studies (2022) 49 (2): 274–289.
Published: 18 February 2021
... to the rapid spread of COVID-19 on January 30, 2020. G10 G14 I10 COVID-19 Abnormal returns Cumulative average abnormal returns Stock market indices WHO © Emerald Publishing Limited 2021 Emerald Publishing Limited Licensed re-use rights only Since the first case of COVID-19...

or Create an Account

Close Modal
Close Modal